CORE LABS INC (CLB)
(Delayed Data from NYSE)
$19.21 USD
+0.03 (0.16%)
Updated Sep 24, 2024 04:00 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Core Laboratories (CLB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$16.75 | $22.00 | $14.00 | -12.81% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Core Laboratories comes to $16.75. The forecasts range from a low of $14.00 to a high of $22.00. The average price target represents a decline of 12.81% from the last closing price of $19.21.
Analyst Price Targets (4 )
Broker Rating
Core Laboratories currently has an average brokerage recommendation (ABR) of 3.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 3.75 a month ago based on four recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 3.75 | 3.75 | 3.75 | 3.60 | 3.60 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/26/2024 | Not Identified | Not Identified | Hold | Hold |
4/1/2024 | Cowen & Co. | Mark Bianchi | Hold | Hold |
2/28/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.75 |
ABR (Last week) | 3.75 |
# of Recs in ABR | 4 |
Average Target Price | $16.75 |
LT Growth Rate | 22.20% |
Industry | Oil and Gas - Field Services |
Industry Rank by ABR | 175 of 253 |
Current Quarter EPS Est: | 0.25 |
CLB FAQs
Core Laboratories Inc. (CLB) currently has an average brokerage recommendation (ABR) of 3.75 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Core Laboratories Inc. (CLB) is $16.75. The current on short-term price targets is based on 3 reports.
The forecasts for Core Laboratories Inc. (CLB) range from a low of $14 to a high of $22. The average price target represents a decline of $12.81 from the last closing price of $19.21.
The current DOWNSIDE for Core Laboratories Inc. (CLB) is 12.81%
Based on short-term price targets offered by four analysts, the average price target for Core Laboratories comes to $16.75. The forecasts range from a low of $14.00 to a high of $22.00. The average price target represents a decline of 12.81% from the last closing price of $19.21.